{
  "docId": "019de070-1001-704a-89ab-d7496f4fd716",
  "docSlug": "51e89351998d2fd4ac099e485858473c",
  "documentTitle": "BioNTech | Results Presentation Deck | 11 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 11,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-1001-704a-89ab-d7496f4fd716/10",
  "deckHref": "/decks/019de070-1001-704a-89ab-d7496f4fd716",
  "deckJsonHref": "/decks/019de070-1001-704a-89ab-d7496f4fd716.json",
  "deckAnchorHref": "/decks/019de070-1001-704a-89ab-d7496f4fd716#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.045,
        "w": 0.795,
        "x": 0.072,
        "y": 0.728
      },
      "kind": "list",
      "text": "Strong momentum toward our vision of building a global immunotherapy company",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2126fedf-072f-4048-958c-d700e6e05220",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.688,
        "x": 0.072,
        "y": 0.428
      },
      "kind": "list",
      "text": "Multiple data read-outs & late-stage trial starts anticipated in 2H 2020",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a33a834d-2a16-4b2a-9672-6b3a7e20ef37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.795,
        "x": 0.072,
        "y": 0.278
      },
      "kind": "list",
      "text": "Rapid progress in key pipeline programs in both oncology and infectious diseases",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b2f57d5a-85d1-47f6-94ad-eda778eb5c4c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.828,
        "x": 0.072,
        "y": 0.578
      },
      "kind": "list",
      "text": "Expanded transatlantic operations with newly established R&D hub in Cambridge, U.S.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f51172d1-d616-4758-9385-7f51ac523356",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.667,
        "x": 0.042,
        "y": 0.105
      },
      "kind": "title",
      "text": "Building a next generation immunotherapy company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "234896ff-8757-47ec-bc24-42aaceed5402",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "ad7b4c30-362f-4768-bef5-0f905e04160e",
      "evidence": "list/bullet: Expanded transatlantic operations with newly established R&D hub in Cambridge, U.S.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "list-presentation",
      "slug": null,
      "matchId": "cc918da4-0599-4029-9214-21e9ec73eb71",
      "evidence": "The slide uses a bulleted list with checkmark icons to present key takeaways.",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 10,
      "from": 4,
      "beatId": "a1e10f88-6e5d-473c-a25a-cabcc03d02ec",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Key Takeaways",
      "beatSlug": null,
      "evidence": "Slides 4 and 10 provide key takeaways on the COVID-19 program and building a next-generation immunotherapy company.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}